PMID: 8970058Dec 1, 1996Paper

Inherited activated protein C resistance in a patient with familial primary antiphospholipid syndrome

The Journal of Rheumatology
D Alarcón-SegoviaA Ruiz-Argüelles

Abstract

The mechanism of thrombophilia in patients with antiphospholipid antibodies (aPL) is not clearly understood. A number of contributing factors have been described, but more than one may be operative. It was recently found that aPL may cause the acquired activated protein C resistance phenotype, whereas in familial thrombophilia, activated protein C resistance frequently results from a point mutation in the factor V gene (replacing arginine 506 with a glutamine) that leads into the (R-506-Q), the so-called Leiden mutation, that produces a mutated factor V, resistant to the catalytic action of activated protein C, otherwise normal in its procoagulant properties. We describe one patient heterozygous for the activated protein C resistance genotype with a familial form of primary antiphospholipid syndrome, who had a nephew who died with this disease. In individuals who are heterozygous for the factor V Leiden mutation, the presence of aPL may cause further activated protein C resistance, resulting in increased thrombophilia.

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
G J Ruiz-ArgüellesA Ruiz-Argüelles
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
G J Ruiz-Argüelles
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
J L Zehnder, M Jain
Archives of Pathology & Laboratory Medicine
Adam Rosendorff, D M Dorfman
© 2021 Meta ULC. All rights reserved